Acadia (ACAD) To Announce Third Quarter 2016 Financial Results On November 7, 2016
11/1/2016 11:45:18 AM
SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in central nervous system disorders, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2016 on Monday, November 7, 2016, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Monday, November 7, 2016, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and operations.
comments powered by